|
ARTL Artelo Biosciences Inc 1621221 |
| Income Statement |
|
Net Income
|
artl_10q
|
-1,132,000 |
| Balance Sheet |
|
Current Assets
|
4,986,000 |
|
Assets
|
7,136,000 |
|
Current Liabilities
|
697,000 |
|
Liabilities
|
775,000 |
|
Equity
|
6,361,000 |
|
Shares Out
|
3,228,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-5,783,000 |
|
Investing Cash Flow
|
7,269,000 |
| Market Analysis |
Market Cap
|
3,750,590 |
|
Price
|
1.15 |
|
BVPS
|
1.97 |
|
PB
|
0.58 |
|
EPS
|
-3.33 |
|
PS
|
0.23 |
|
FCF
|
1,486,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARTL documents filed with the SEC.
ARTL Filings
Clear
